Bent Jakobsen is the founder of Accession Therapeutics. Accession Therapeutics has raised $53M in total funding. Latest round: Seed. Based in Oxford, UK.
Bent Jakobsen is the founder and CEO of Accession Therapeutics, a clinical-stage biopharmaceutical company based in Oxford, UK, focused on developing immune-oncology therapeutics. He previously founded Adaptimmune Therapeutics plc and Immunocore Holdings plc.
Full founder directory · Investor directory · Company funding database · Fundraising library